McDermott advises GPP on acquiring a majority stake in Eutecma

McDermott Will & Emery advised Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the healthcare industry, on the acquisition of a majority stake in Eutecma, a German-based developer of packaging solutions for pharmaceutical cold chain shipments.

With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its Refreshment Centers.

Founded in 2008, Eutecma is a leading designer and manufacturer of sustainable, modular, and reusable temperature-controlled packaging solutions for the pharmaceutical industry.

The company is headquartered in Mannheim, Germany, with Refreshment Centers in the EU and the US.

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe.

The McDermott team advising GPP was led by partner Jan Hückel, and comprised partners Thomas Ammermann, Robert Clagg, Nathan Barnett, Eleanore West, Jana Grieb, Heiko Kermer, Carina Kant, Daniel Zucker, Brian Mead, Nick Paul, Jeffrey Holdvogt, Barrick Bollman, Jeff Cassidy, counsel Marcus Fischer, Laura Stammwitz, Bettina Holzberger, Raymond Paretzky,  as well as associates Darius Mosleh, Malte Arndt, Marisa Montoya, Katharina Hoffmeister, Carina Schützeberg, Lennart Neumann and Anja Bertrand.

Learn more about McDermott Will & Emery at mwe.com